HIGHLIGHTS
- who: Jingzhu Zhao from the Antioquia, Colombia have published the research work: Anlotinib in patients with medullary thyroid carcinoma with negative prognostic factors: A sub-analysis based on the ALTER01031 study, in the Journal: (JOURNAL) of September/30,/2018
- what: Study design and participants This analysis assessed subgroups of patients with older age and bone metastasis from ALTER01031, which was a frontiersin.org 10.3389/fonc.2022.852032 complete and partial responses. The post-hoc analysis focusing on patients of different ages in the placebo group indicated that age > 50 years was significantly related with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.